160 related articles for article (PubMed ID: 33606061)
1. F-18 FDG perfusion PET: intraprocedural assessment of the liver tumor ablation margin.
Shyn PB; Cubre AJ; Catalano PJ; Lee LK; Hyun H; Tuncali K; Seol JG; Levesque VM; Gerbaudo VH; Kapur T; Chao RT; Silverman SG
Abdom Radiol (NY); 2021 Jul; 46(7):3437-3447. PubMed ID: 33606061
[TBL] [Abstract][Full Text] [Related]
2. Assessing ablation margins of FDG-avid liver tumors during PET/CT-guided thermal ablation procedures: a retrospective study.
Casadaban LC; Catalano PJ; Lee LK; Hyun H; Tuncali K; Gerbaudo VH; Shyn PB
Eur J Nucl Med Mol Imaging; 2021 Aug; 48(9):2914-2924. PubMed ID: 33559712
[TBL] [Abstract][Full Text] [Related]
3. Intraprocedural Ablation Margin Assessment by Using Ammonia Perfusion PET during FDG PET/CT-guided Liver Tumor Ablation: A Pilot Study.
Shyn PB; Casadaban LC; Sainani NI; Sadow CA; Bunch PM; Levesque VM; Kim CK; Gerbaudo VH; Silverman SG
Radiology; 2018 Jul; 288(1):138-145. PubMed ID: 29613843
[TBL] [Abstract][Full Text] [Related]
4. Liver tumor F-18 FDG-PET before and immediately after microwave ablation enables imaging and quantification of tumor tissue contraction.
Yan Z; Khorasani R; Levesque VM; Gerbaudo VH; Shyn PB
Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1618-1625. PubMed ID: 33175240
[TBL] [Abstract][Full Text] [Related]
5. Immediate Postablation
Cornelis FH; Petre EN; Vakiani E; Klimstra D; Durack JC; Gonen M; Osborne J; Solomon SB; Sofocleous CT
J Nucl Med; 2018 Sep; 59(9):1360-1365. PubMed ID: 29439012
[TBL] [Abstract][Full Text] [Related]
6. 18F-FDG PET/CT Is an Immediate Imaging Biomarker of Treatment Success After Liver Metastasis Ablation.
Cornelis F; Sotirchos V; Violari E; Sofocleous CT; Schoder H; Durack JC; Siegelbaum RH; Maybody M; Humm J; Solomon SB
J Nucl Med; 2016 Jul; 57(7):1052-7. PubMed ID: 26912433
[TBL] [Abstract][Full Text] [Related]
7. Gradient-based Volumetric PET Parameters on Immediate Pre-ablation FDG-PET Predict Local Tumor Progression in Patients with Colorectal Liver Metastasis Treated by Microwave Ablation.
Zirakchian Zadeh M; Yeh R; Kirov AS; Kunin HS; Gönen M; Sotirchos VS; Soares KS; Sofocleous CT
Cardiovasc Intervent Radiol; 2023 Jul; 46(7):911-920. PubMed ID: 37268735
[TBL] [Abstract][Full Text] [Related]
8. Real-Time US-
Mauri G; Gennaro N; De Beni S; Ierace T; Goldberg SN; Rodari M; Solbiati LA
Cardiovasc Intervent Radiol; 2019 Jan; 42(1):60-68. PubMed ID: 30288593
[TBL] [Abstract][Full Text] [Related]
9. Split-Dose
Zhao JM; Gusman M; Peacock JG; Wickley AB; Banks KP
J Nucl Med Technol; 2019 Mar; 47(1):88-89. PubMed ID: 30683689
[TBL] [Abstract][Full Text] [Related]
10. Real-time FDG PET guidance during biopsies and radiofrequency ablation using multimodality fusion with electromagnetic navigation.
Venkatesan AM; Kadoury S; Abi-Jaoudeh N; Levy EB; Maass-Moreno R; Krücker J; Dalal S; Xu S; Glossop N; Wood BJ
Radiology; 2011 Sep; 260(3):848-56. PubMed ID: 21734159
[TBL] [Abstract][Full Text] [Related]
11. Split-dose technique for FDG PET/CT-guided percutaneous ablation: a method to facilitate lesion targeting and to provide immediate assessment of treatment effectiveness.
Ryan ER; Sofocleous CT; Schöder H; Carrasquillo JA; Nehmeh S; Larson SM; Thornton R; Siegelbaum RH; Erinjeri JP; Solomon SB
Radiology; 2013 Jul; 268(1):288-95. PubMed ID: 23564714
[TBL] [Abstract][Full Text] [Related]
12. [Clinical value of (18)F-FDG positron emission tomography-computed tomography in local liver neoplasm ablation].
Liao WJ; Wu HB; Chen JZ; Shi M; You CX; Wang QS
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Aug; 29(8):1641-2. PubMed ID: 19726317
[TBL] [Abstract][Full Text] [Related]
13. Tumor and Ablation Margin Visibility during Cryoablation of Musculoskeletal Tumors: Comparing Intraprocedural PET/CT Images with CT-Only Images.
Burch EA; Bhagavatula SK; Malone FE; Reichert RR; Tuncali K; Levesque VM; Lan Z; Sticka WT; Shyn PB
J Vasc Interv Radiol; 2023 Aug; 34(8):1311-1318. PubMed ID: 37028704
[TBL] [Abstract][Full Text] [Related]
14. The use of PET-MRI in the follow-up after radiofrequency- and microwave ablation of colorectal liver metastases.
Nielsen K; Scheffer HJ; Pieters IC; van Tilborg AA; van Waesberghe JH; Oprea-Lager DE; Meijerink MR; Kazemier G; Hoekstra OS; Schreurs HW; Sietses C; Meijer S; Comans EF; van den Tol PM
BMC Med Imaging; 2014 Aug; 14():27. PubMed ID: 25103913
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic accuracy of CE-CT, MRI and FDG PET/CT for detecting colorectal cancer liver metastases in patients considered eligible for hepatic resection and/or local ablation.
Sivesgaard K; Larsen LP; Sørensen M; Kramer S; Schlander S; Amanavicius N; Bharadwaz A; Tønner Nielsen D; Viborg Mortensen F; Morre Pedersen E
Eur Radiol; 2018 Nov; 28(11):4735-4747. PubMed ID: 29736846
[TBL] [Abstract][Full Text] [Related]
16. PET/CT-guided radiofrequency and cryoablation: is tumor fluorine-18 fluorodeoxyglucose activity dissipated by thermal ablation?
Sainani NI; Shyn PB; Tatli S; Morrison PR; Tuncali K; Silverman SG
J Vasc Interv Radiol; 2011 Mar; 22(3):354-60. PubMed ID: 21353987
[TBL] [Abstract][Full Text] [Related]
17. Three-Dimensional Margin as a Predictor of Local Tumor Progression after Microwave Ablation: Intraprocedural versus 4-8-Week Postablation Assessment.
Zirakchian Zadeh M; Sotirchos VS; Kirov A; Lafontaine D; Gönen M; Yeh R; Kunin H; Petre EN; Kitsel Y; Elsayed M; Solomon SB; Erinjeri JP; Schwartz LH; Sofocleous CT
J Vasc Interv Radiol; 2024 Apr; 35(4):523-532.e1. PubMed ID: 38215818
[TBL] [Abstract][Full Text] [Related]
18. FDG positron emission tomography in the surveillance of hepatic tumors treated with radiofrequency ablation.
Anderson GS; Brinkmann F; Soulen MC; Alavi A; Zhuang H
Clin Nucl Med; 2003 Mar; 28(3):192-7. PubMed ID: 12592125
[TBL] [Abstract][Full Text] [Related]
19. Intraprocedural Versus Initial Follow-up Minimal Ablative Margin Assessment After Colorectal Liver Metastasis Thermal Ablation: Which One Better Predicts Local Outcomes?
Lin YM; Paolucci I; Albuquerque Marques Silva J; O'Connor CS; Fellman BM; Jones AK; Kuban JD; Huang SY; Metwalli ZA; Brock KK; Odisio BC
Invest Radiol; 2024 Apr; 59(4):314-319. PubMed ID: 37812469
[TBL] [Abstract][Full Text] [Related]
20. [F-18] fluorodeoxyglucose positron emission tomography as a tool for early recognition of incomplete tumor destruction after radiofrequency ablation for liver metastases.
Donckier V; Van Laethem JL; Goldman S; Van Gansbeke D; Feron P; Ickx B; Wikler D; Gelin M
J Surg Oncol; 2003 Dec; 84(4):215-23. PubMed ID: 14756432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
